We are live on ! Find out more
SRTS icon

Sensus Healthcare

11 hedge funds and large institutions have $4.38M invested in Sensus Healthcare in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.78% less ownership

Funds ownership: 8.84%8.06% (-0.78%)

8% less funds holding

Funds holding: 1211 (-1)

17% less capital invested

Capital invested by funds: $5.25M → $4.38M (-$867K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SRTS Hedge Fund Activity: Q2 2017 in Review

11 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2017, worth a combined $4.38M — down 17% from $5.25M a quarter earlier.

Fund positioning in SRTS was balanced in Q2 2017: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was B. Riley Financial, opening a new position worth an estimated $422K. The largest seller was RTW Investments, exiting entirely with an estimated $397K sold.

  • 11 institutional investors held Sensus Healthcare (SRTS) as of Q2 2017, down from 12 in Q1 2017.
  • Funds reported $4.38M of Sensus Healthcare stock for Q2 2017, down 17% quarter-over-quarter.
  • 3 funds opened new Sensus Healthcare positions in Q2 2017 and 3 closed out, a net change of 0 holders.
  • The largest Sensus Healthcare buyer in Q2 2017 was B. Riley Financial, an estimated $422K added.
  • The largest Sensus Healthcare seller in Q2 2017 was RTW Investments, an estimated $397K sold.

Based on aggregated 13F filings for Q2 2017.